Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Passot

Showing results (251-260 of 356) with videos related to

Pageof 36
Sort By:
Clinical Pharmacokinetics|July 13, 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer PatientsSarah Lobet, Gilles Paintaud, Nicolas Azzopardi, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 26, 2017
Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapyMohammad Alyami, Bradford J Kim, Laurent Villeneuve, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 2010
Is nasal carriage of Staphylococcus aureus the main acquisition pathway for surgical-site infection in orthopaedic surgery?P Berthelot, F Grattard, C Cazorla, et al.
Annals of Surgical Oncology|November 19, 2020
Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center StudyAditi Bhatt, Pascal Rousset, Nazim Benzerdjeb, et al.
World Journal of Surgery|March 14, 2022
An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyFrederic Mercier, Guillaume Passot, Pierre-Emmanuel Bonnot, et al.
Annals of Surgical Oncology|February 2, 2023
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective StudyFlorian Fanget, Amaniel Kefleyesus, Julien Peron, et al.
Annals of Surgical Oncology|December 15, 2017
Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 PatientsFrederic Mercier, Guillaume Passot, Laurent Villeneuve, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2017
Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in MiceChristophe Arnoult, Guillaume Brachet, Diana Cadena Castaneda, et al.
Surgical Endoscopy|July 14, 2018
A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysisA Arjona-Sanchez, J Esquivel, O Glehen, et al.
Annals of Surgical Oncology|March 27, 2014
Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosisGuillaume Passot, Benoît You, Gilles Boschetti, et al.
Pageof 36

Showing results (251-260 of 356) with videos related to

Sort By:
Pageof 36
Clinical Pharmacokinetics|July 13, 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer PatientsSarah Lobet, Gilles Paintaud, Nicolas Azzopardi, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 26, 2017
Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapyMohammad Alyami, Bradford J Kim, Laurent Villeneuve, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 2010
Is nasal carriage of Staphylococcus aureus the main acquisition pathway for surgical-site infection in orthopaedic surgery?P Berthelot, F Grattard, C Cazorla, et al.
Annals of Surgical Oncology|November 19, 2020
Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center StudyAditi Bhatt, Pascal Rousset, Nazim Benzerdjeb, et al.
World Journal of Surgery|March 14, 2022
An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyFrederic Mercier, Guillaume Passot, Pierre-Emmanuel Bonnot, et al.
Annals of Surgical Oncology|February 2, 2023
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective StudyFlorian Fanget, Amaniel Kefleyesus, Julien Peron, et al.
Annals of Surgical Oncology|December 15, 2017
Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 PatientsFrederic Mercier, Guillaume Passot, Laurent Villeneuve, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2017
Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-α Antibodies after a Single Injection in MiceChristophe Arnoult, Guillaume Brachet, Diana Cadena Castaneda, et al.
Surgical Endoscopy|July 14, 2018
A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysisA Arjona-Sanchez, J Esquivel, O Glehen, et al.
Annals of Surgical Oncology|March 27, 2014
Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosisGuillaume Passot, Benoît You, Gilles Boschetti, et al.
Pageof 36